文献速递类风湿关节炎

抗丙二醛-乙醛抗体在类风湿关节炎诊断前及在其他疾病特异性自身抗体之后被检测到

Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies.
PubMed 文献 · Arthritis Rheumatol · 2020-10-15

该研究评估了类风湿关节炎(RA)诊断前血清抗丙二醛-乙醛(MAA)抗体水平,发现IgG和IgA型抗MAA抗体分别在诊断前3.0年和2.3年与对照组出现差异,晚于抗CCP-2(17.6年)和IgM-RF(7.2年)。

要点

  • IgG和IgA抗MAA抗体在RA诊断前数年即升高,但出现时间晚于抗CCP-2和IgM-RF。
  • 三种抗MAA抗体同种型均与诊断前抗CCP-2和RF浓度显著相关。
  • MAA形成及抗MAA免疫反应可能参与从亚临床自身免疫向临床关节炎的转变。

核心结论

  • IgG和IgA抗MAA自身抗体在RA诊断前即升高,但在临床前病程中出现晚于抗CCP-2或RF。

研究设计与样本

  • 研究纳入214例RA病例和210例对照,检测诊断前后血清抗MAA抗体同种型、抗CCP-2和IgM-RF浓度。

主要发现

  • RA患者IgG抗MAA抗体在诊断前3.0年与对照组出现差异(log2差异0.34,P<0.05)。
  • RA患者IgA抗MAA抗体在诊断前2.3年与对照组出现差异(log2差异0.43,P<0.05)。
  • IgM抗MAA抗体浓度未见病例对照差异。
  • 抗CCP-2和IgM-RF浓度分别在诊断前17.6年和7.2年开始与对照组出现差异。
  • 诊断前所有三种抗MAA抗体同种型均与抗CCP-2和RF浓度显著相关(IgM-RF β=0.22-0.27;抗CCP-2 β=0.44-0.93;P<0.001)。

临床怎么用

  • 抗MAA抗体可能作为RA临床前阶段的补充标志物,但出现较晚,不宜替代抗CCP-2或RF用于早期风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine serum autoantibodies to malondialdehyde-acetaldehyde (MAA) prior to rheumatoid arthritis (RA) diagnosis. METHODS: Concentrations of anti-MAA antibody isotypes, anti-cyclic citrullinated peptide 2 (anti-CCP-2), and IgM rheumatoid factor (IgM-RF) were evaluated before and after RA diagnosis in samples from cases (n = 214) and controls (n = 210). The timing of elevations in autoantibody concentrations relative to RA diagnosis was explored using separate mixed models for each antibody and/or isotype. Associations between prediagnosis autoantibody concentrations in RA patients were examined using mixed effects linear regression models. RESULTS: Concentrations of IgG (log2 difference 0.34) and IgA (log2 difference 0.43) anti-MAA antibodies in RA patients diverged from controls at 3.0 years and 2.3 years prior to diagnosis, respectively (P < 0.05 for both). There was no evidence of case-control divergence for IgM anti-MAA antibody concentration. Anti-CCP-2 and IgM-RF concentrations diverged between RA patients and controls beginning at 17.6 years and 7.2 years prior to RA diagnosis, respectively. All 3 anti-MAA antibody isotypes (IgA, IgM, and IgG) were significantly associated with anti-CCP-2 antibody and RF concentrations prior to diagnosis (β = 0.22-0.27 for IgM-RF; β = 0.44-0.93 for anti-CCP-2) (P < 0.001). CONCLUSION: IgG and IgA anti-MAA autoantibodies are elevated prior to RA diagnosis but appear later in the preclinical course than anti-CCP-2 or RF. These findings suggest that MAA formation and anti-MAA immune responses could play a role in the transition from subclinical autoimmunity to clinically apparent arthritis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Mikuls TR, Edison J, Meeshaw E, et al. Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies. Arthritis Rheumatol. 2020. PMID: 32621635. doi:10.1002/art.41424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。